Ursachen der Potenzierung der hypoglykämischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente
- 1 December 1971
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 4 (1), 32-37
- https://doi.org/10.1007/bf00568896
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ursachen der Potenzierung der hypoglykämischen Wirkung von Sulfonylharnstoff-Derivaten durch MedikamenteEuropean Journal of Clinical Pharmacology, 1971
- Abbauhemmung von tolbutamid durch sulfaphenazol beim menschenEuropean Journal of Clinical Pharmacology, 1970
- [HB 419, a new oral antidiabetic; administration to the aged].1969
- [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].1969
- [Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].1969
- [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].1969
- [Severe hypoglycemia reactions following treatment with tolbutamide, carbutamide and chlorpropamide (report on 14 cases, studies on clinical symptoms and pathogenesis)].1968
- Potentiation of Acetohexamide Hypoglycemia by PhenylbutazoneNew England Journal of Medicine, 1967
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963
- MitteilungJuristische Rundschau, 1959